Michael T. Barrett

8.1k total citations · 1 hit paper
99 papers, 4.2k citations indexed

About

Michael T. Barrett is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Michael T. Barrett has authored 99 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cancer Research, 40 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Michael T. Barrett's work include Cancer Genomics and Diagnostics (43 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Genetic factors in colorectal cancer (13 papers). Michael T. Barrett is often cited by papers focused on Cancer Genomics and Diagnostics (43 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Genetic factors in colorectal cancer (13 papers). Michael T. Barrett collaborates with scholars based in United States, Canada and Switzerland. Michael T. Barrett's co-authors include Brian J. Reid, Patricia C. Galipeau, Carissa A. Sanchez, David J. Wong, Mary J. Emond, Peter S. Rabinovitch, Scott A. Foster, Denise A. Galloway, Douglas S. Levine and David Cowan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Michael T. Barrett

94 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clonal competition with alternating dominance in multiple myeloma

2012 456 citations Jonathan J. Keats, Marta Chesi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael T. Barrett United States	34	1.9k	1.4k	1.1k	965	840	99	4.2k
Martina Olivero Italy	33	3.0k 1.6×	1.5k 1.1×	813 0.7×	958 1.0×	743 0.9×	80	5.6k
Jane Houldsworth United States	41	2.5k 1.3×	1.2k 0.9×	811 0.7×	1.5k 1.6×	717 0.9×	111	5.1k
Mireia Castillo-Martín United States	36	3.9k 2.1×	1.5k 1.1×	1.3k 1.2×	1.1k 1.1×	1.0k 1.2×	107	6.1k
Charles Spruck United States	36	4.0k 2.1×	2.4k 1.8×	937 0.9×	1.1k 1.1×	463 0.6×	58	5.9k
Nicholas A. Willis United States	18	3.7k 2.0×	2.3k 1.7×	998 0.9×	467 0.5×	721 0.9×	37	5.4k
Bjørn Risberg Norway	41	1.8k 0.9×	1.4k 1.0×	877 0.8×	512 0.5×	761 0.9×	131	4.6k
Cristina E. Tognon United States	26	2.0k 1.1×	980 0.7×	705 0.6×	307 0.3×	509 0.6×	81	3.6k
Catherine I. Dumur United States	34	1.7k 0.9×	1.0k 0.8×	693 0.6×	513 0.5×	463 0.6×	94	3.4k
Pulivarthi H. Rao United States	52	4.2k 2.2×	2.5k 1.8×	1.4k 1.3×	1.2k 1.2×	911 1.1×	129	7.7k
Mariano Monzó Spain	41	4.0k 2.1×	1.7k 1.2×	3.1k 2.8×	379 0.4×	813 1.0×	143	6.1k

Countries citing papers authored by Michael T. Barrett

Since Specialization

Citations

This map shows the geographic impact of Michael T. Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Barrett more than expected).

Fields of papers citing papers by Michael T. Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Barrett. The network helps show where Michael T. Barrett may publish in the future.

Co-authorship network of co-authors of Michael T. Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Barrett. A scholar is included among the top collaborators of Michael T. Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Barrett. Michael T. Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Sarah H., James B. Smadbeck, Roman M. Zenka, et al.. (2025). Tumor ploidy determination in low-pass whole genome sequencing and allelic copy number visualization using the Constellation Plot. Genome biology. 26(1). 132–132.

Zhou, Yumei, Xianfeng Chen, Jun Chen, et al.. (2024). Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer. Scientific Reports. 14(1). 9368–9368. 3 indexed citations

Jameson, Gayle, Peter J. Hosein, Mandana Kamgar, et al.. (2024). Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer Medicine. 13(12).

Kosiorek, Heidi, et al.. (2024). Abstract PO1-18-07: Phase I trial of combination pembrolizumab and ruxolitinib in metastatic triple negative breast cancer. Cancer Research. 84(9_Supplement). PO1–18.

Barrett, Michael T., Faye R. Harris, Ryan W. Feathers, et al.. (2021). Combination targeted treatment may enhance antitumor activity in ERBB3 amplified high-grade serous endometrial cancer cells resistant to single agent targeted therapy. Gynecologic Oncology. 162. S114–S115.

Xu, Jingying, Ashley Margol, Anju Shukla, et al.. (2015). Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia. Frontiers in Oncology. 5. 191–191. 17 indexed citations

Cherba, David, et al.. (2014). Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts. Molecular Oncology. 8(7). 1253–1265. 6 indexed citations

Stieber, Daniel, Anna Golebiewska, Lisa Evers, et al.. (2013). Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathologica. 127(2). 203–219. 81 indexed citations

Barrett, Michael T., Elizabeth Lenkiewicz, Lisa Evers, et al.. (2013). Clonal Evolution and Therapeutic Resistance in Solid Tumors. Frontiers in Pharmacology. 4. 2–2. 20 indexed citations

10.

Keats, Jonathan J., Marta Chesi, Jan B. Egan, et al.. (2012). Clonal competition with alternating dominance in multiple myeloma. Blood. 120(5). 1067–1076. 456 indexed citations breakdown →

11.

Holley, Tara, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples. PLoS ONE. 7(11). e50586–e50586. 38 indexed citations

12.

Ruiz, Christian, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2011). Advancing a clinically relevant perspective of the clonal nature of cancer. Proceedings of the National Academy of Sciences. 108(29). 12054–12059. 90 indexed citations

13.

Pandita, Ajay, Jane Bayani, Jana Paděrová, et al.. (2011). Integrated Cytogenetic and High-Resolution Array CGH Analysis of Genomic Alterations Associated with <i>MYCN</i> Amplification. Cytogenetic and Genome Research. 134(1). 27–39. 5 indexed citations

14.

Lai, Lisa A., Rumen Kostadinov, Michael T. Barrett, et al.. (2010). Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus. Molecular Cancer Research. 8(8). 1084–1094. 36 indexed citations

15.

Garrido‐Laguna, Ignacio, Aik Choon Tan, Maria Uson, et al.. (2010). Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. British Journal of Cancer. 103(5). 649–655. 62 indexed citations

16.

Robbins, Christiane M., Angela Baker, Shripad Sinari, et al.. (2010). Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Research. 21(1). 47–55. 134 indexed citations

17.

Hostetter, Galen, Su Young Kim, Stephanie Savage, et al.. (2009). Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples. Nucleic Acids Research. 38(2). e9–e9. 31 indexed citations

18.

Basu, Gargi D., David O. Azorsa, Jeffrey Kiefer, et al.. (2008). Functional evidence implicating S100P in prostate cancer progression. International Journal of Cancer. 123(2). 330–339. 62 indexed citations

19.

Bernardini, Marcus Q., Anya Tsalenko, Paula Marrano, et al.. (2008). High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin‐resistant ovarian cancer cells. Genes Chromosomes and Cancer. 47(5). 427–436. 16 indexed citations

20.

Andrulis, Irene L. & Michael T. Barrett. (1989). DNA Methylation Patterns Associated with Asparagine Synthetase Expression in Asparagine-Overproducing and -Auxotrophic Cells. Molecular and Cellular Biology. 9(7). 2922–2927. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact